drugset / Trial / NCT06811220
The Effect of Oral Administration of Hesperidin and Diosmin in Reducing Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients
RandomizedParallel-groupOpen-labelSupportive care
Summary
The aim of this study is evaluation of the potential neuroprotective effect of oral hesperidin and diosmin in reducing paclitaxel- induced peripheral neuropathy in the treatment of breast cancer patients.
Timeline
- Start
- 2025-01-27
- Primary completion
- 2025-12-31
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Diosmin | Small molecule | 450 mg | Oral |
| Comparator | Hesperidin | Small molecule | 50 mg | Oral |